Brand A - Search Results

1

[Immunotherapy of cancer with interleukin-2 and with interleukin-2 activated cells].

Osanto S, Brand A, van Rood JJ, Cleton FJ. Osanto S, et al. Among authors: brand a. Ned Tijdschr Geneeskd. 1989 Jul 15;133(28):1392-5. Ned Tijdschr Geneeskd. 1989. PMID: 2677758 Review. Dutch. No abstract available.

2

Hypothyroidism during immunotherapy with interleukin-2 is associated with antithyroid antibodies and response to treatment.

Weijl NI, Van der Harst D, Brand A, Kooy Y, Van Luxemburg S, Schroder J, Lentjes E, Van Rood JJ, Cleton FJ, Osanto S. Weijl NI, et al. Among authors: brand a. J Clin Oncol. 1993 Jul;11(7):1376-83. doi: 10.1200/JCO.1993.11.7.1376. J Clin Oncol. 1993. PMID: 8315436 Clinical Trial.

3

Increased numbers of circulating haematopoietic progenitor cells after treatment with high-dose interleukin-2 in cancer patients.

Schaafsma MR, Fibbe WE, van der Harst D, Duinkerken N, Brand A, Osanto S, Franks CR, Willemze R, Falkenburg JH. Schaafsma MR, et al. Among authors: brand a. Br J Haematol. 1990 Oct;76(2):180-5. doi: 10.1111/j.1365-2141.1990.tb07869.x. Br J Haematol. 1990. PMID: 2094321 Clinical Trial.

4

[Bone marrow transplantation and (or) immunosuppression with antithymocyte globulin in the treatment of aplastic anemia].

Zwaan FE, Haak HL, van der Meer CW, Guiot HF, Hartgrink-Groeneveld CA, den Ottolander GJ, Willemze R, Eernisse JG, Brand A, van Rood JJ, Kunst MW, te Velde J, Noordwijk EM. Zwaan FE, et al. Among authors: brand a. Ned Tijdschr Geneeskd. 1978 Mar 11;122(10):326-32. Ned Tijdschr Geneeskd. 1978. PMID: 24811 Dutch. No abstract available.

5

Lymphokine-activated killer cells selectively kill tumor cells in bone marrow without compromising bone marrow stem cell function in vitro.

van den Brink MR, Voogt PJ, Marijt WA, van Luxemburg-Heys SA, van Rood JJ, Brand A. van den Brink MR, et al. Among authors: brand a. Blood. 1989 Jul;74(1):354-60. Blood. 1989. PMID: 2787676 Free article.

6

Lymphokine-activated killer cell functions in patients with leukemic B-lymphoproliferative diseases.

van der Harst D, Brand A, van Luxemburg-Heys SA, Kooy-Winkelaar EM, van Rood JJ. van der Harst D, et al. Among authors: brand a. Blood. 1989 Nov 15;74(7):2464-70. Blood. 1989. PMID: 2804374 Free article.

7

UV-irradiated platelets: ready to use?

Brand A, Claas FH, van Rood JJ. Brand A, et al. Transfusion. 1989 Jun;29(5):377-8. doi: 10.1046/j.1537-2995.1989.29589284133.x. Transfusion. 1989. PMID: 2734818 No abstract available.

8

Cell-mediated lysis of human hematopoietic progenitor cells.

Voogt PJ, Fibbe WE, Veenhof WF, Brand A, Goulmy E, van Rood JJ, Falkenburg JH. Voogt PJ, et al. Among authors: brand a. Leukemia. 1987 May;1(5):427-31. Leukemia. 1987. PMID: 3499546

9

Perioperative blood transfusion and cancer prognosis. Different effects of blood transfusion on prognosis of colon and breast cancer patients.

Voogt PJ, van de Velde CJ, Brand A, Hermans J, Stijnen T, Bloem R, Leer JW, Zwaveling A, van Rood JJ. Voogt PJ, et al. Among authors: brand a. Cancer. 1987 Feb 15;59(4):836-43. doi: 10.1002/1097-0142(19870215)59:4<836::aid-cncr2820590430>3.0.co;2-s. Cancer. 1987. PMID: 3802042

10

Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: spontaneous and therapeutic.

Lundkvist I, van Doorn PA, Vermeulen M, van Lint M, van Rood JJ, Brand A. Lundkvist I, et al. Among authors: brand a. Immunol Rev. 1989 Aug;110:105-17. doi: 10.1111/j.1600-065x.1989.tb00029.x. Immunol Rev. 1989. PMID: 2676844 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,354 results

Search Page

Filters